Atlas Trials

Congenital Erythropoietic Porphyria (CEP)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Congenital Erythropoietic Porphyria (CEP)

RecordFirmDate
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP (NCT07024316)Atlas Molecular Pharma2026-01-29

Track Congenital Erythropoietic Porphyria (CEP) automatically

Every clearance here is in the API, with alerts when new ones post.